1. Home
  2. NCNO vs TMDX Comparison

NCNO vs TMDX Comparison

Compare NCNO & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NCNO
  • TMDX
  • Stock Information
  • Founded
  • NCNO 2011
  • TMDX 1998
  • Country
  • NCNO United States
  • TMDX United States
  • Employees
  • NCNO N/A
  • TMDX N/A
  • Industry
  • NCNO Computer Software: Prepackaged Software
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • NCNO Technology
  • TMDX Health Care
  • Exchange
  • NCNO Nasdaq
  • TMDX Nasdaq
  • Market Cap
  • NCNO 2.7B
  • TMDX 2.3B
  • IPO Year
  • NCNO 2020
  • TMDX 2019
  • Fundamental
  • Price
  • NCNO $24.03
  • TMDX $111.50
  • Analyst Decision
  • NCNO Buy
  • TMDX Buy
  • Analyst Count
  • NCNO 15
  • TMDX 10
  • Target Price
  • NCNO $28.93
  • TMDX $122.89
  • AVG Volume (30 Days)
  • NCNO 1.9M
  • TMDX 1.3M
  • Earning Date
  • NCNO 05-28-2025
  • TMDX 05-08-2025
  • Dividend Yield
  • NCNO N/A
  • TMDX N/A
  • EPS Growth
  • NCNO N/A
  • TMDX N/A
  • EPS
  • NCNO N/A
  • TMDX 1.41
  • Revenue
  • NCNO $540,657,000.00
  • TMDX $488,227,000.00
  • Revenue This Year
  • NCNO $9.25
  • TMDX $25.33
  • Revenue Next Year
  • NCNO $8.11
  • TMDX $20.53
  • P/E Ratio
  • NCNO N/A
  • TMDX $79.28
  • Revenue Growth
  • NCNO 13.45
  • TMDX 64.43
  • 52 Week Low
  • NCNO $18.75
  • TMDX $55.00
  • 52 Week High
  • NCNO $43.20
  • TMDX $177.37
  • Technical
  • Relative Strength Index (RSI)
  • NCNO 50.24
  • TMDX 78.52
  • Support Level
  • NCNO $21.73
  • TMDX $92.49
  • Resistance Level
  • NCNO $23.64
  • TMDX $95.71
  • Average True Range (ATR)
  • NCNO 0.77
  • TMDX 4.79
  • MACD
  • NCNO 0.30
  • TMDX 0.81
  • Stochastic Oscillator
  • NCNO 92.18
  • TMDX 71.36

About NCNO nCino Inc.

Ncino Inc is a provider of cloud-based software for financial institutions. Its software solution digitizes, automates, and streamlines inefficient and complex processes & workflows and utilizes data analytics & artificial intelligence that enables financial institutions to onboard new clients, make loans, and manage the entire loan life cycle, open deposits, and other accounts, and manage regulatory compliance. It also offers professional services, including configuration & implementation, training, and advisory services. The company generates the majority of its revenue from subscription services. The company caters to financial institutions, enterprise banks, regional banks, community banks, and credit unions. The vast majority of its revenue comes from the United States.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: